First-in-Human Evaluation of an Astrocytic Glutamate Transporter (EAAT2) PET Tracer in Dementia

NCT05374278 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

102

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer Disease
Frontotemporal Dementia
Dementia

Interventions

DRUG: [18F]RP-115 PET/MRI or PET/CT and MRI

Sponsor

David Wilson

Collaborators

[object Object]